Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLUTAMICS: Glutamate for Heart Protection in Unstable CAD Surgery
NCT00489827Phase 3Completed
- Start
- Oct 2005
- Primary completion
- Dec 2009
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Glutamic acid in coronary artery disease (CAD) (2 arms). Primary endpoint: Number of Participants With Perioperative Myocardial Infarction, Postoperative Heart Failure or Postoperative Mortality at 30 days. Started Oct 2005; status: completed.
02
Drugs
Glutamic acid
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00489827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489827.